These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4229543)

  • 1. The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
    Ramachandran BV
    Biochem Pharmacol; 1967 Nov; 16(11):2061-8. PubMed ID: 4229543
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo action of diisopropylfluorophosphate, of atropine and their synergism on acetylcholinesterase activity.
    Molinengo L; Ghi P
    Pharmacology; 1989; 39(3):154-9. PubMed ID: 2587621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of DF32P in mouse organs. II. The effect of prophylactically administered oximes and atropine on incorporation and toxicity.
    Ramachandran BV
    Biochem Pharmacol; 1966 Oct; 15(10):1577-87. PubMed ID: 5971810
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae.
    Sánchez-Fortún S; Barahona MV
    Ecotoxicol Environ Saf; 2009 Mar; 72(3):775-80. PubMed ID: 18191451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potentiation by anticholinesterase drugs of the responses of the guinea-pig isolated vas deferens to alternate preganglionic and postganglionic stimulation.
    Birmingham AT
    Br J Pharmacol Chemother; 1966 May; 27(1):145-56. PubMed ID: 6006720
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo protection of diisopropylphosphorofluoridate (DFP) poisoning by three bis-quaternary 2 -(hydroxyimino) -N -(pyridin-3-yl) acetamide derivatives in Swiss mice.
    Kumar P; Swami D; Karade HN; Acharya J; Jatav PC; Kumar A; Meena MK
    Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):53-9. PubMed ID: 25346249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oximes on the distribution of 32P in the body of the rat after injection of 32P-sarin.
    Polak RL; Cohen EM
    Biochem Pharmacol; 1970 Mar; 19(3):865-76. PubMed ID: 5507691
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial antagonism by cholinesterase reactivators of the effects of organophosphate compounds on shuttle-box avoidance.
    Rosić N
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):139-47. PubMed ID: 5437315
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of oximes on isolated organs intoxicated with organophosphorus anticholinesterases.
    van der Meer C; Wolthuis OL
    Biochem Pharmacol; 1965 Sep; 14(9):1299-312. PubMed ID: 5857534
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
    Schmidt J; Wolf H
    Acta Biol Med Ger; 1972; 29(4):723-8. PubMed ID: 4653305
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional study of the renal effect of the anticholimesterase paraoxon.
    Williams RL; Pearson JE
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):195-208. PubMed ID: 5448768
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine.
    Galli A; Mori F
    J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection Against Diisopropylfluorophosphate in Acute Hippocampal Slices.
    Ferchmin PA; Pérez D; Cuadrado BL; Carrasco M; Martins AH; Eterović VA
    Neurochem Res; 2015 Oct; 40(10):2143-51. PubMed ID: 26438150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS effects of anticholinesterases in the presence of inhibited cholinesterases.
    Van Meter WG; Karczmar AG; Fiscus RR
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):249-60. PubMed ID: 646523
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of organophosphates on nerve conduction.
    Sechzer PH
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):432-41. PubMed ID: 5868744
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of organophosphates on bioelectrical activity of the brain.
    Rump S
    Pol J Pharmacol Pharm; 1990; 42(6):563-72. PubMed ID: 2103006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.